Efficacy and Safety of LB1410 Plus Lenvatinib With or Without LB4330 in Advanced Recurrent/Metastatic Cervical Cancer
Clinical trial NCT07177716 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07177716
- Sponsor
- L & L Bio Co., Ltd., Ningbo, China
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-10-01
- Primary completion
- 2028-12-01
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.